About therapeutic antibodies

History of therapeutic antibodies

1890
Dr. Shibasaburo Kitasato and Dr. Bering discovered that the serum obtained from an animal infected with diphtheria was effective in the treatment of diphtheria and tetanus; they established serum therapy. (*1-1,*1-2)
1959
Gerald Edelman and Rodney Porter determined the molecular structure of antibodies. (*2-1,*2-2)
1975
César Milstein, Georges Köhler and Niels Kaj Jerne established the hybridoma technology, which is a technology for producing monoclonal antibodies. (*3)
1976
Dr. Susumu Tonegawa discovered the genetic principle for the generation of antibody diversity. (*4)
1986
The world's first therapeutic antibody "muromonab" was approved. (*5)
1990s
Antibody engineering technologies were established. (*6)
2005
Japan’s first therapeutic antibody "tocilizumab" was approved. (*7)
As of2022
More than 100 therapeutic antibodies have been approved in Japan, Europe, and the United States. (*8)
BACK TO TOP